Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Erasca Q2 EPS $(1.20) Down From $(0.26) YoY

Erasca (NASDAQ:ERAS) reported quarterly losses of $(1.20) per share. This is a 361.54 percent decrease over losses of $(0.26) per share from the same period last year.

byBenzinga Newsdesk

August 26, 2021

1 minute read

Erasca (NASDAQ:ERAS) reported quarterly losses of $(1.20) per share. This is a 361.54 percent decrease over losses of $(0.26) per share from the same period last year.

Assured Guaranty Q2 EPS $1.59 Beats $0.76 Estimate, Sales $102.00M Miss $180.60M Estimate

By Benzinga Newsdesk

Today, 10:27 PM

Assured Guaranty (NYSE:AGO) reported quarterly earnings of $1.59 per share which beat the analyst consensus estimate of $0.76 by 109.21 percent. This is a 16.91 percent increase over earnings of $1.36 per share from the

AGO

Analysts Tick Up Dell Price Target Post Q3 Beat

By Anusuya Lahiri

Today, 10:27 PM

Analysts raised their price targets

DELL

ON Semiconductor Shares Soar On Q3 Beat, Stellar Q4 Outlook

By Anusuya Lahiri

Today, 10:27 PM

ON Semiconductor Corp (NASDAQ:ON) reported third-quarter FY21 revenue growth of 32% year-on-year to $1.74 billion, beating the consensus of $1.71 billion.…

Conformis Actera Hip System Receives 510(k) Clearance From The U.S. FDA

By Benzinga Newsdesk

Today, 10:27 PM

Conformis, Inc. (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, today announced that it has received 510(k) clearance from the U.S. Food and Drug

CFMS

Erasca Q2 EPS $(1.20) Down From $(0.26) YoY

Related Posts

Assured Guaranty Q2 EPS $1.59 Beats $0.76 Estimate, Sales $102.00M Miss $180.60M Estimate

Analysts Tick Up Dell Price Target Post Q3 Beat

ON Semiconductor Shares Soar On Q3 Beat, Stellar Q4 Outlook

Conformis Actera Hip System Receives 510(k) Clearance From The U.S. FDA